{"id":"https://openalex.org/W2167777181","doi":"https://doi.org/10.1007/s11095-010-0297-1","title":"Strategies for the Assessment of Protein Aggregates in Pharmaceutical Biotech Product Development","display_name":"Strategies for the Assessment of Protein Aggregates in Pharmaceutical Biotech Product Development","publication_year":2010,"publication_date":"2010-10-22","ids":{"openalex":"https://openalex.org/W2167777181","doi":"https://doi.org/10.1007/s11095-010-0297-1","mag":"2167777181","pmid":"https://pubmed.ncbi.nlm.nih.gov/20972611","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3063870"},"language":"en","primary_location":{"id":"doi:10.1007/s11095-010-0297-1","doi":"https://doi.org/10.1007/s11095-010-0297-1","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11095-010-0297-1","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11095-010-0297-1.pdf","source":{"id":"https://openalex.org/S103865650","display_name":"Pharmaceutical Research","issn_l":"0724-8741","issn":["0724-8741","1573-904X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s11095-010-0297-1.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071102062","display_name":"John den Engelsman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162999","display_name":"MSD (Netherlands)","ror":"https://ror.org/05y28vr04","country_code":"NL","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210162999"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"John den Engelsman","raw_affiliation_strings":["Biological and Sterile Product Development, MSD, Oss, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological and Sterile Product Development, MSD, Oss, The Netherlands","institution_ids":["https://openalex.org/I4210162999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042228448","display_name":"Patrick Garidel","orcid":"https://orcid.org/0000-0001-9512-9533","observed_orcids":["https://orcid.org/0000-0001-9512-9533"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Patrick Garidel","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG, Department of Process Science/Biopharmaceuticals, Biberach an der Riss, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Department of Process Science/Biopharmaceuticals, Biberach an der Riss, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034635312","display_name":"Ronald A. Smulders","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162999","display_name":"MSD (Netherlands)","ror":"https://ror.org/05y28vr04","country_code":"NL","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210162999"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Ronald Smulders","raw_affiliation_strings":["Biological and Sterile Product Development, MSD, Oss, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological and Sterile Product Development, MSD, Oss, The Netherlands","institution_ids":["https://openalex.org/I4210162999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029298052","display_name":"Hans Koll","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094361","display_name":"Roche Pharma AG (Germany)","ror":"https://ror.org/00sh68184","country_code":"DE","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210094361"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Hans Koll","raw_affiliation_strings":["Biologics Research \u2013 Protein Analytics, Roche Pharma Research and Early Development, Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biologics Research \u2013 Protein Analytics, Roche Pharma Research and Early Development, Penzberg, Germany","institution_ids":["https://openalex.org/I4210094361"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Bryan Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134054","display_name":"UCB Pharma (United Kingdom)","ror":"https://ror.org/03428qp74","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210134054","https://openalex.org/I85722119"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Bryan Smith","raw_affiliation_strings":["UCB, Slough, Berkshire, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB, Slough, Berkshire, UK","institution_ids":["https://openalex.org/I4210134054"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109217444","display_name":"Stefan Bassarab","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Stefan Bassarab","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG, Department of Process Science/Biopharmaceuticals, Biberach an der Riss, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Department of Process Science/Biopharmaceuticals, Biberach an der Riss, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065334266","display_name":"Andreas Seidl","orcid":"https://orcid.org/0009-0002-1019-2125","observed_orcids":["https://orcid.org/0009-0002-1019-2125"]},"institutions":[{"id":"https://openalex.org/I4210090224","display_name":"Hexal (Germany)","ror":"https://ror.org/00abnnq69","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210090224"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andreas Seidl","raw_affiliation_strings":["Sandoz Biopharmaceuticals, Analytical Characterization, Hexal AG, Oberhaching, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sandoz Biopharmaceuticals, Analytical Characterization, Hexal AG, Oberhaching, Germany","institution_ids":["https://openalex.org/I4210090224"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048042850","display_name":"Otmar Hainzl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090224","display_name":"Hexal (Germany)","ror":"https://ror.org/00abnnq69","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210090224"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Otmar Hainzl","raw_affiliation_strings":["Sandoz Biopharmaceuticals, Analytical Characterization, Hexal AG, Oberhaching, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sandoz Biopharmaceuticals, Analytical Characterization, Hexal AG, Oberhaching, Germany","institution_ids":["https://openalex.org/I4210090224"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031708632","display_name":"Wim Jiskoot","orcid":"https://orcid.org/0000-0002-1012-3456","observed_orcids":["https://orcid.org/0000-0002-1012-3456","https://orcid.org/0000-0001-7081-7890"]},"institutions":[{"id":"https://openalex.org/I121797337","display_name":"Leiden University","ror":"https://ror.org/027bh9e22","country_code":"NL","type":"education","lineage":["https://openalex.org/I121797337"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Wim Jiskoot","raw_affiliation_strings":["Division of Drug Delivery Technology Leiden/Amsterdam Center for Drug Research, Leiden University, P.O. Box 9502, 2300 RA, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Drug Delivery Technology Leiden/Amsterdam Center for Drug Research, Leiden University, P.O. Box 9502, 2300 RA, Leiden, The Netherlands","institution_ids":["https://openalex.org/I121797337"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5031708632"],"corresponding_institution_ids":["https://openalex.org/I121797337"],"apc_list":{"value":4690,"currency":"USD","value_usd":4690},"apc_paid":{"value":4690,"currency":"USD","value_usd":4690},"fwci":5.6283,"has_fulltext":true,"cited_by_count":363,"citation_normalized_percentile":{"value":0.97506758,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"28","issue":"4","first_page":"920","last_page":"933"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.017100000753998756,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11663","display_name":"Viral Infectious Diseases and Gene Expression in Insects","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/protein-aggregates","display_name":"protein aggregates","score":0.968999981880188},{"id":"https://openalex.org/keywords/protein-characterization","display_name":"protein characterization","score":0.8399999737739563},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.9290000200271606},{"id":"https://openalex.org/keywords/therapeutic-proteins","display_name":"therapeutic proteins","score":0.8899999856948853}],"concepts":[{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.6543834805488586},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.5251445770263672},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34362882375717163},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.33767902851104736},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22218170762062073},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.10159105062484741},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001709","descriptor_name":"Biotechnology","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D001709","descriptor_name":"Biotechnology","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false},{"descriptor_ui":"D004340","descriptor_name":"Drug Contamination","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D005062","descriptor_name":"European Union","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007118","descriptor_name":"Immunoassay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011786","descriptor_name":"Quality Control","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013678","descriptor_name":"Technology, Pharmaceutical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D013678","descriptor_name":"Technology, Pharmaceutical","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false},{"descriptor_ui":"D017408","descriptor_name":"Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017510","descriptor_name":"Protein Folding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1007/s11095-010-0297-1","doi":"https://doi.org/10.1007/s11095-010-0297-1","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11095-010-0297-1","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11095-010-0297-1.pdf","source":{"id":"https://openalex.org/S103865650","display_name":"Pharmaceutical Research","issn_l":"0724-8741","issn":["0724-8741","1573-904X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Research","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2082146","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3063870","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3063870","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3063870","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharm Res","raw_type":"Text"},{"id":"pmid:20972611","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20972611","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical research","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s11095-010-0297-1","doi":"https://doi.org/10.1007/s11095-010-0297-1","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11095-010-0297-1","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11095-010-0297-1.pdf","source":{"id":"https://openalex.org/S103865650","display_name":"Pharmaceutical Research","issn_l":"0724-8741","issn":["0724-8741","1573-904X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Research","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.7246000170707703}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2167777181.pdf","grobid_xml":"https://content.openalex.org/works/W2167777181.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W159986488","https://openalex.org/W1581858536","https://openalex.org/W1634384702","https://openalex.org/W1967800067","https://openalex.org/W2001633803","https://openalex.org/W2007228224","https://openalex.org/W2015060415","https://openalex.org/W2015082998","https://openalex.org/W2016546400","https://openalex.org/W2017224547","https://openalex.org/W2020658869","https://openalex.org/W2027397388","https://openalex.org/W2028219230","https://openalex.org/W2034274579","https://openalex.org/W2042601819","https://openalex.org/W2047565601","https://openalex.org/W2048049691","https://openalex.org/W2053295432","https://openalex.org/W2061187228","https://openalex.org/W2066722574","https://openalex.org/W2071095038","https://openalex.org/W2100861268","https://openalex.org/W2106357609","https://openalex.org/W2106907072","https://openalex.org/W2109798607","https://openalex.org/W2111877521","https://openalex.org/W2115882312","https://openalex.org/W2122748934","https://openalex.org/W2127519720","https://openalex.org/W2129365134","https://openalex.org/W2138317859","https://openalex.org/W6863951927"],"related_works":["https://openalex.org/W7099968371","https://openalex.org/W2048981144","https://openalex.org/W2281597363","https://openalex.org/W2012557883","https://openalex.org/W2063766942","https://openalex.org/W3034500342","https://openalex.org/W2407553074","https://openalex.org/W2060422244","https://openalex.org/W2215497400","https://openalex.org/W2059027334"],"abstract_inverted_index":{"Within":[0],"the":[1,9,39,66,77],"European":[2],"Immunogenicity":[3],"Platform":[4],"(EIP)":[5],"(":[6],"http://www.e-i-p.eu":[7],"),":[8],"Protein":[10],"Characterization":[11],"Subcommittee":[12],"(EIP-PCS)":[13],"has":[14],"been":[15],"established":[16],"to":[17,27,65,71],"discuss":[18],"and":[19,62],"exchange":[20],"experience":[21],"of":[22,36,42,46,79],"protein":[23,47,80],"characterization":[24],"in":[25],"relation":[26],"unwanted":[28],"immunogenicity.":[29],"In":[30],"this":[31],"commentary,":[32],"we,":[33],"as":[34],"representatives":[35],"EIP-PCS,":[37],"review":[38],"current":[40],"state":[41],"methods":[43,55],"for":[44,73],"analysis":[45],"aggregates.":[48],"Moreover,":[49],"we":[50],"elaborate":[51],"on":[52],"why":[53],"these":[54],"should":[56],"be":[57],"used":[58],"during":[59,76],"product":[60],"development":[61,78],"make":[63],"recommendations":[64],"biotech":[67],"community":[68],"with":[69],"regard":[70],"strategies":[72],"their":[74],"application":[75],"therapeutics.":[81]},"counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":31},{"year":2023,"cited_by_count":33},{"year":2022,"cited_by_count":20},{"year":2021,"cited_by_count":35},{"year":2020,"cited_by_count":29},{"year":2019,"cited_by_count":21},{"year":2018,"cited_by_count":25},{"year":2017,"cited_by_count":26},{"year":2016,"cited_by_count":21},{"year":2015,"cited_by_count":26},{"year":2014,"cited_by_count":20},{"year":2013,"cited_by_count":20},{"year":2012,"cited_by_count":25}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}